Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/56917
Title: FEBCON-ED Study: Does advice to give regular antipyretics for children presenting with a FEBrile CONvulsion to the Emergency Department reduce the rate of seizure reoccurrence within the same febrile illness?
Monash Health Investigator(s): Craig S. 
Monash Health Department(s): Monash University - School of Clinical Sciences at Monash Health
Paediatric - General Paediatrics
Registration Date: 13-Jun-2023
Monash Health Site(s): Monash Children's Hospital
Summary: The main purpose of this study is to help determine whether recommending the use of paracetamol or ibuprofen makes any difference to the risk of another febrile convulsion (fit) within the same illness in children aged 6 months- 6 years old who have presented to the ED with a febrile convulsion. The study will also help determine whether paracetamol or ibuprofen given regularly reduces hospital re-attendance with febrile convulsion, health care use and costs. We are also interested in long-term outcomes of children who have had a febrile convulsion. Information will be collected for the study by parent/guardian surveys on enrolment, days 3,7 and at 12 months, and medical chart review (and optional data linkage) at 12 months post ED attendance. Febrile convulsions are the most common paediatric neurological presentation to the emergency department. Depending on our study findings, we will either confirm current practice, or provide definitive evidence to change practice to update clinical guidelines in AUS & NZ to recommend this simple, low-cost intervention to improve management of febrile convulsions.
Type: Clinical trial
Registry ID: ACTRN12623000638639
URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385595
Appears in Collections:Clinical Trials

Show full item record

Page view(s)

120
checked on May 23, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.